Skip to main content

L 6 (Lamivudine 300 mg)

Pill with imprint L 6 is Gray, Capsule-shape and has been identified as Lamivudine 300 mg. It is supplied by Lupin Pharmaceuticals, Inc.

Lamivudine is used in the treatment of hiv infection; hepatitis b; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Lamivudine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for L 6

Lamivudine 300 mg L 6
Lamivudine 300 mg L 6
Lamivudine 300 mg L 6


L 6
300 mg
Prescription only
Drug Class
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Lupin Pharmaceuticals, Inc.
National Drug Code (NDC)
Inactive Ingredients
microcrystalline cellulose, crospovidone, ferrosoferric oxide, hypromelloses, magnesium stearate, polyethylene glycol, povidone, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "L 6"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.